H.R. 1627 · 119th Congress
TREATS Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
D
NorcrossSponsor31 cosponsors · 23 D, 8 R
R
Fitzpatrick
DB
R
Bacon
NB
D
Barragán
SC
D
Cohen
GC
D
Connolly
DD
D
Davis
CD
D
Deluzio
DD
D
Dingell
CH
D
Houlahan
JH
D
Harder
HJ
D
Johnson
JJ
D
Jackson
WK
D
Keating
ML
R
Lawler
SM
D
Moulton
CM
R
Miller
JO
R
Obernolte
BP
D
Pettersen
MS
D
Scanlon
PT
D
Tonko
CT
R
Tenney
LT
D
Trahan
JT
D
Tokuda
DW
D
Wasserman Schultz
GT
R
Thompson
JK
R
Kiggans
BB
D
Balint
SL
D
Liccardo
AC
D
Craig
RT
D
Torres
EN
D
Norton1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act
What it does: CRS summary · Introduced in House · Feb 26, 2025
Telehealth Response for E-prescribing Addiction Therapy Services Act or the TREATS Act
This bill permanently allows health care practitioners to prescribe certain controlled substances for treating substance use disorders via telehealth without evaluating the patient in person.
Generally, a health care practitioner may not prescribe a controlled substance via telehealth unless they first conduct an in-person medical evaluation. Federal regulations currently provide a temporary exception to this requirement, allowing practitioners to prescribe schedule II-V controlled substances for legitimate medical purposes (such as treating substance use disorders) via telehealth without an in-person evaluation. However, this temporary regulatory flexibility expires on December 31, 2025.
The bill permanently allows practitioners to prescribe schedule III-V controlled substances for the treatment of a substance use disorder via telehealth without conducting an in-person evaluation. In such instances, a practitioner may conduct a telehealth evaluation using audio-only or audio and video equipment.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: TREATS Act
Also known as: Telehealth Response for E-prescribing Addiction Therapy Services Act
Latest action (Feb 26, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Policy area: Health · Origin: House · Introduced: Feb 26, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.